cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
17. Dezember 2024 08:00 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
12. November 2024 16:05 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics to Participate in Upcoming Investor Conferences
05. November 2024 16:05 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics to Participate in Upcoming Investor Conferences
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity
05. November 2024 09:23 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
12. August 2024 16:05 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
22157.jpg
CD19/CD20 Bi-Specific CAR-T Pipeline Research Report 2024: In-depth Analysis of the Pipeline Assets, Therapeutic Assessment and Comparative Analysis
18. Juli 2024 07:21 ET | Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "CD19/CD20 Bi-Specific CAR-T - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.CD19/CD20 Bi-Specific CAR-T...
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
10. Juli 2024 08:00 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
22157.jpg
CAR-T Therapy Pipeline Landscape Report, 2024 - Features Insights on Emerging Drugs CT053, Descartes-08, ALLO-501A, CTX110, and IMPT 314
14. Juni 2024 06:23 ET | Research and Markets
Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "CAR-T Therapy - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.This report provides in-depth insights into the...
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
04. Juni 2024 16:05 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
28. Mai 2024 08:00 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing